Skip to main content
VA Rating Assistant
Estimate

These guides are AI-generated educational summaries — not legal or medical advice.

C&P Exam Prep: Hepatitis C (Chronic Viral)

DC 7354 digestive 38 CFR 4.114

DBQ Overview

Interview + Physical
Form Name
liver-conditions
Form Code
liver-conditions
Page Count
9
Examiner Type
Gastroenterologist or Hepatologist
Estimated Duration
30-45 minutes
Exam Format
Interview + Physical

What to Expect During Your Exam

Exam Overview

To document the current severity of your Hepatitis C infection and any resulting liver damage, complications, or systemic symptoms for VA disability rating purposes under DC 7354 (rated by analogy under DC 7345 - Chronic liver disease without cirrhosis).

What the examiner evaluates:

  • Diagnosis confirmation (Hepatitis C) and date of diagnosis
  • Current symptoms including fatigue, malaise, anorexia, abdominal pain, pruritus, weakness, and arthralgia
  • Laboratory findings: AST, ALT, bilirubin, alkaline phosphatase, INR/PT, creatinine, albumin, viral titers, and HCV genotype
  • Imaging results: ultrasound, CT, MRI/MRCP, EUS
  • MELD score (Model for End-Stage Liver Disease) - critical for rating level
  • Presence of cirrhosis-related complications: portal hypertension, splenomegaly, ascites, coagulopathy, hepatic encephalopathy, variceal hemorrhage, portal gastropathy, hepatopulmonary syndrome, hepatorenal syndrome, spontaneous bacterial peritonitis
  • Treatment history including antiviral therapy (parenteral or oral), immunomodulatory therapy, and any continuous medication requirements
  • Functional impact: how symptoms affect daily activities, work capacity, and quality of life
  • History of liver transplant if applicable
  • Any concurrent liver conditions (cirrhosis, liver cancer, NASH)

Exam will include a medical history interview and physical examination of the abdomen. Examiner will review lab values and imaging. Bring all recent labs and imaging reports. Exam may be conducted in person or via telehealth (confirm format in advance). In most states you have the right to record the exam - notify the examiner at the start.

Typical duration: 30-45 minutes

AST (Aspartate Aminotransferase) and ALT (Alanine Aminotransferase)

Liver enzyme levels indicating hepatocellular inflammation or damage

What to expect:

Blood test review - examiner will document most recent values and trend over time. Normal AST/ALT is approximately 10-40 U/L. Elevated values reflect ongoing liver inflammation.

Key thresholds:

  • Normal range (10-40 U/L) — May support 0% if truly asymptomatic with no functional impairment
  • Mildly elevated (1-3x ULN) — Supports 20% rating level - continuous medication required
  • Moderately elevated (3-10x ULN) — Supports 40-60% rating consideration with associated symptoms
  • Severely elevated or persistently high with symptoms — Supports 60-100% evaluation depending on MELD score and complications

Tips:

  • Bring printed lab results from the past 12-24 months to show trends
  • Note dates when labs were drawn and whether you had flares at that time
  • Ask your treating provider to write a letter describing liver function trends over time

Pain considerations: Elevated liver enzymes alone do not capture fatigue, malaise, or abdominal pain. Ensure you verbally describe all symptoms even if labs appear only mildly elevated.

MELD Score (Model for End-Stage Liver Disease)

Calculated severity score based on bilirubin, INR, creatinine, and sodium. Directly drives cirrhosis rating levels under DC 7312 and is relevant if cirrhosis is present alongside HCV.

What to expect:

Examiner will calculate or reference your most recent MELD score from records. Scores range from 6 to 40+.

Key thresholds:

  • MELD - 9 — Supports lower rating levels (20-40%) absent other complications
  • MELD 10-11 — Supports 40% (with portal hypertension signs such as splenomegaly or ascites)
  • MELD > 11 but < 15 — Supports 60% with daily fatigue and at least one annual complication episode
  • MELD - 15 — Supports 100% if combined with continuous daily debilitating symptoms and qualifying complications

Tips:

  • If you have cirrhosis secondary to HCV, ask your hepatologist for your most current MELD or MELD-Na score in writing
  • Request that your treating physician document how the score has changed over time
  • MELD score is only part of the 100% picture - the examiner must also document qualifying complications

Pain considerations: MELD score is objective but does not reflect subjective burden. Always supplement with a detailed description of how daily debilitating symptoms affect your functioning.

Bilirubin (Total and Direct)

Liver's ability to process and excrete bile; elevated levels indicate hepatic dysfunction and may cause jaundice and pruritus

What to expect:

Blood test result review. Normal total bilirubin is 0.2-1.2 mg/dL. Elevated levels are used in MELD calculation and reflect disease progression.

Key thresholds:

  • Normal (< 1.2 mg/dL) — Baseline; absence of jaundice does not preclude symptoms
  • Mildly elevated (1.2-3.0 mg/dL) — Signals worsening hepatic function; supports mid-range rating with symptoms
  • Significantly elevated (> 3.0 mg/dL) — Supports higher rating levels; visible jaundice likely present

Tips:

  • Describe any history of jaundice (yellowing of skin or eyes) even if resolved
  • Note whether pruritus (itching) is present as this directly ties to elevated bilirubin
  • Bring all labs within the past 12-24 months

Pain considerations: Pruritus from elevated bilirubin can be severely disabling and interfere with sleep. Describe its severity, frequency, and impact on rest and daily function.

INR / Prothrombin Time (PT)

Clotting ability; reflects the liver's synthetic function. Elevated INR indicates coagulopathy, a key rating criterion.

What to expect:

Lab review. Normal INR is approximately 0.8-1.2. Elevated INR is used in MELD score calculation and indicates coagulopathy.

Key thresholds:

  • INR < 1.5 — Near-normal clotting; coagulopathy less likely documented
  • INR - 1.5 — Significant coagulopathy; supports 100% criteria if combined with other qualifying complications

Tips:

  • Coagulopathy is one of the qualifying complications for a 100% rating under DC 7312 (applicable if cirrhosis is present)
  • Report any history of easy bruising, prolonged bleeding from cuts, or bleeding gums
  • Bring recent INR results, especially if you have been monitored for clotting issues

Pain considerations: Coagulopathy creates anxiety and functional limitations (e.g., avoiding activities that risk injury). Describe how fear of bleeding affects your daily choices and quality of life.

HCV Viral Load (Hepatitis C Viral Titers) and Genotype

Viral load confirms active infection and response to treatment; genotype determines treatment selection

What to expect:

Lab review or blood draw. Examiner documents detectable vs. undetectable viral RNA and HCV genotype (1a, 1b, 2, 3, etc.).

Key thresholds:

  • Undetectable viral load (SVR achieved) — Sustained virologic response does NOT automatically result in 0%; ongoing hepatic damage and symptoms must still be evaluated
  • Detectable viral load — Active infection; supports rating based on current symptom severity and lab findings

Tips:

  • Even if you achieved SVR (sustained virologic response) after treatment, you may still have significant liver damage (fibrosis, cirrhosis) warranting a ratable disability
  • Bring documentation of your treatment history including drug regimen, start and end dates, and SVR status
  • If viral load is now undetectable, ensure the examiner still evaluates all residual liver damage and symptoms

Pain considerations: SVR does not mean your liver is healthy. Describe all ongoing symptoms even after successful antiviral treatment, as residual hepatic fibrosis and fatigue often persist.

Alkaline Phosphatase (ALP)

Enzyme associated with bile duct function; elevated levels can indicate cholestatic disease or hepatic injury

What to expect:

Blood test review. Normal range approximately 44-147 U/L. Elevation in HCV context suggests advancing liver disease or concurrent biliary involvement.

Key thresholds:

  • Normal (44-147 U/L) — Does not negate other symptoms
  • Elevated (> 3x ULN) — Suggests significant hepatic involvement; supports higher rating when combined with symptoms

Tips:

  • Report if you have been told you have bile duct involvement or cholestatic features
  • Bring all liver function panel results

Pain considerations: Elevated ALP can contribute to pruritus and fatigue. Link laboratory findings directly to your described symptoms.

Creatinine / Renal Function Panel

Kidney function; relevant because hepatorenal syndrome (a complication of advanced liver disease) affects renal function

What to expect:

Lab review. Normal creatinine approximately 0.6-1.2 mg/dL. Used in MELD score calculation.

Key thresholds:

  • Creatinine > 1.5 mg/dL in context of liver disease — Raises concern for hepatorenal syndrome; supports 100% rating level if criteria met

Tips:

  • If you have kidney problems related to liver disease, ensure this is documented
  • Ask your treating physician if hepatorenal syndrome has ever been diagnosed or suspected

Pain considerations: Hepatorenal syndrome is a severe complication that significantly limits function. If present, describe all associated symptoms including edema, decreased urine output, and fatigue.

Liver Biopsy / Fibroscan / Elastography

Degree of hepatic fibrosis and inflammation; establishes stage of liver disease

What to expect:

Review of any prior biopsy pathology reports or non-invasive fibrosis assessment results. Examiner documents fibrosis stage (F0-F4 / Metavir scale).

Key thresholds:

  • F0-F1 (minimal fibrosis) — Supports lower rating levels with symptom correlation
  • F2-F3 (significant fibrosis) — Supports mid-range ratings (20-40%) with symptoms
  • F4 (cirrhosis) — Triggers evaluation under DC 7312 in addition to DC 7354/7345; cirrhosis complications are key rating drivers

Tips:

  • Bring copies of all biopsy reports and fibroscan results
  • If fibrosis stage is F4, ensure examiner documents cirrhosis diagnosis and evaluates for all qualifying complications
  • If you have not had a fibroscan, ask your treating provider if one is warranted

Pain considerations: Fibrosis stage alone does not capture functional impairment. Always pair objective staging data with a full description of how your symptoms affect your daily life.

Estimate

Rating Criteria Breakdown

100% MELD score - 15; OR continuous daily debilitating symptoms w ...

MELD score - 15; OR continuous daily debilitating symptoms with generalized weakness AND at least one of: ascites, spontaneous bacterial peritonitis, hepatic encephalopathy, variceal hemorrhage, coagulopathy, portal gastropathy, or hepatopulmonary/hepatorenal syndrome. Veteran is essentially incapacitated.

Key Symptoms

  • MELD score - 15
  • Continuous daily debilitating symptoms
  • Generalized weakness
  • Ascites
  • History of spontaneous bacterial peritonitis
  • Hepatic encephalopathy
  • Variceal hemorrhage
  • Coagulopathy
  • Portal gastropathy
  • Hepatopulmonary syndrome
  • Hepatorenal syndrome

CFR: DC 7312 (applicable when cirrhosis is present alongside HCV DC 7354) - 100%: MELD - 15; or continuous daily debilitating symptoms with generalized weakness plus at least one qualifying complication. Veteran cannot maintain gainful employment or normal daily activities.

60% MELD score > 11 but < 15; OR daily fatigue AND at least one ...

MELD score > 11 but < 15; OR daily fatigue AND at least one episode in the last year of either variceal hemorrhage, portal gastropathy, or hepatic encephalopathy. Significant functional impairment.

Key Symptoms

  • MELD score > 11 and < 15
  • Daily fatigue
  • At least one annual episode of variceal hemorrhage
  • Portal gastropathy episodes
  • Hepatic encephalopathy episodes
  • Requiring parenteral antiviral therapy
  • Requiring parenteral immunomodulatory therapy

CFR: DC 7345 / 7312 - 60%: Liver disease with MELD score > 11 but < 15; or with daily fatigue and at least one episode per year of variceal hemorrhage, portal gastropathy, or hepatic encephalopathy. Also applies if requiring parenteral antiviral or immunomodulatory therapy.

40% MELD score of 10-11; OR signs of portal hypertension such as ...

MELD score of 10-11; OR signs of portal hypertension such as splenomegaly or ascites AND either weakness or anorexia, or fatigue, or malaise. Symptoms are regular but not fully debilitating.

Key Symptoms

  • MELD score 10-11
  • Portal hypertension
  • Splenomegaly
  • Ascites (fluid in abdomen)
  • Weakness
  • Anorexia
  • Fatigue
  • Malaise
  • Daily fatigue with functional limitation

CFR: DC 7345 / 7312 - 40%: Liver disease with MELD score 10-11; or with signs of portal hypertension such as splenomegaly or ascites and either weakness, anorexia, or other debilitating symptoms. Veteran has measurable liver dysfunction impacting daily activities.

20% Requiring continuous medication but otherwise asymptomatic, ...

Requiring continuous medication but otherwise asymptomatic, or with intermittent symptoms that do not significantly impair daily functioning. Liver enzymes may be mildly elevated.

Key Symptoms

  • Requiring continuous medication (oral antiviral, symptom management)
  • Intermittent fatigue
  • Mild anorexia
  • Intermittent nausea
  • Mildly abnormal liver function tests

CFR: DC 7345 - 20%: Requiring continuous medication. Veteran takes daily medication to manage HCV symptoms or liver function but maintains near-normal daily activities.

0% Asymptomatic but with a history of liver disease; OR conditi ...

Asymptomatic but with a history of liver disease; OR condition resolved following liver transplant. No active symptoms, no functional impairment, normal or near-normal lab values.

Key Symptoms

  • No current symptoms
  • History of liver disease only
  • Normal liver function tests
  • Sustained virologic response with no residual impairment

CFR: Rated under DC 7345 - 0%: Asymptomatic with history of liver disease only, or resolved following liver transplant. Under DC 7354, HCV is rated by analogy to DC 7345.

How to Describe Your Symptoms

Fatigue and Malaise

How to describe:

Describe fatigue as it actually affects your daily life - not just tiredness but a profound exhaustion that does not resolve with rest. Specify how many hours per day you experience fatigue, whether it prevents you from completing tasks, and how it has changed over time. Use concrete examples: 'I need to rest after showering,' 'I cannot work a full day,' or 'I nap 2-3 hours daily despite sleeping 9 hours at night.'

Worst-day example:

“On my worst days, I wake up feeling as though I have not slept at all. I cannot stand long enough to cook a meal. I have cancelled plans with family because I cannot leave the couch. My fatigue is so severe that I need assistance with basic household tasks and have missed work multiple times per month.”

What the examiner listens for:

Whether fatigue is daily vs. intermittent, severity on a functional scale, whether it prevents gainful employment, and whether it is documented in treating records. Examiner will correlate with DBQ fields for 'daily fatigue' and 'continuous daily debilitating symptoms.'

Understatements to avoid:

Do not say 'I get tired sometimes' or 'I manage okay.' This underrepresents the severity. Specify frequency, duration, and the concrete activities you cannot perform.

Abdominal Pain and Discomfort

How to describe:

Locate the pain specifically (right upper quadrant is typical for liver involvement). Rate it on a 0-10 scale for average days and worst days. Describe its character (dull, aching, cramping, sharp), frequency (daily, episodic), duration, and any triggers (eating, exertion, stress). Note if it disrupts sleep or requires you to limit activities.

Worst-day example:

“On my worst days, the pain in my right side is a 7 out of 10. It radiates to my shoulder. I cannot sit comfortably for more than 30 minutes. I have taken prescribed pain medication that does not fully relieve it. I have had to leave work early multiple times due to this pain.”

What the examiner listens for:

Location, severity, frequency, functional impact, relationship to meals and activity, and whether it correlates with documented abnormal labs or imaging findings.

Understatements to avoid:

Do not minimize pain by saying 'it's not that bad.' If you have had to adjust your life around the pain - taking medications, avoiding certain foods, limiting activities - that constitutes significant functional impairment.

Generalized Weakness

How to describe:

Distinguish between fatigue-related weakness and true muscle weakness. Describe specific activities you can no longer perform or have had to limit: carrying groceries, climbing stairs, yard work, standing for prolonged periods. Quantify how long you can stand, walk, or engage in physical activity before weakness forces you to stop.

Worst-day example:

“On bad days, I cannot carry a bag of groceries from the car to the door without stopping to rest. I have difficulty rising from a chair without using my arms. I cannot stand at a counter for more than 10 minutes. This weakness has forced me to stop doing household tasks I previously handled without issue.”

What the examiner listens for:

Whether weakness is generalized vs. localized, its functional impact on activities of daily living, and whether it is present daily or episodically. 'Generalized weakness' is a specific criterion for the 100% rating level under DC 7312.

Understatements to avoid:

Do not conflate weakness with laziness or attribute it to other causes. Be clear that the weakness is directly tied to your Hepatitis C and liver disease.

Cognitive and Neurological Symptoms (Hepatic Encephalopathy)

How to describe:

Describe any episodes of confusion, memory loss, difficulty concentrating, personality changes, disorientation, or trouble with word-finding. Note whether episodes have required medical attention or hospitalization, their frequency, duration, and whether any precipitating factors (infection, dehydration, medications) were identified.

Worst-day example:

“During my worst episodes, I have been confused about what day it is and unable to recall recent conversations. My family has had to remind me of appointments. I have gotten lost driving to familiar places. My doctor has documented two hospitalizations in the past year for hepatic encephalopathy.”

What the examiner listens for:

History of documented hepatic encephalopathy episodes, dates and frequency, any hospitalizations, current cognitive symptoms, and whether episodes are recurring. Hepatic encephalopathy is one of the qualifying complications for both 60% and 100% ratings.

Understatements to avoid:

Do not dismiss cognitive symptoms as 'just brain fog' or attribute them solely to stress or age. If your provider has ever mentioned ammonia levels or hepatic encephalopathy, state that explicitly.

Anorexia and Weight Loss

How to describe:

Describe loss of appetite in terms of how it has changed your eating habits and body weight. Document your baseline weight before illness, current weight, and timeline of loss. Describe whether you feel nauseated when eating, whether food has lost appeal, and how reduced intake affects your energy and ability to function.

Worst-day example:

“On my worst days, I have no appetite at all and force myself to eat small amounts. I have lost 25 pounds over the past 18 months without trying. My treating physician has expressed concern about malnutrition. I cannot eat a full meal without feeling ill.”

What the examiner listens for:

Documented weight loss with baseline and current weights, relationship to liver disease, nutritional status, and severity of anorexia. The DBQ specifically asks for baseline and current weight if weight loss is checked.

Understatements to avoid:

Do not say you 'eat less than you used to' without quantifying the loss. Provide specific numbers: prior weight, current weight, and timeframe.

Pruritus (Itching)

How to describe:

Describe whether itching is localized or generalized, its severity, time of day (often worse at night), whether it disrupts sleep, and what treatments you have tried. Note if scratching has caused skin damage, infections, or scarring.

Worst-day example:

“The itching keeps me awake most nights. I scratch until my skin bleeds and have developed secondary skin infections from scratching. Despite using prescribed antihistamines and topical treatments, the itching is only partially controlled and significantly impacts my quality of life and sleep.”

What the examiner listens for:

Whether pruritus is documented in medical records, its severity and impact on sleep, any treatments used, and its relationship to elevated bilirubin or cholestatic features.

Understatements to avoid:

Do not minimize pruritus as 'occasional itching.' If it disrupts sleep and daily function, say so clearly and describe what you have tried to manage it.

Arthralgia (Joint Pain)

How to describe:

HCV can cause extrahepatic joint pain. Describe which joints are affected, severity (0-10 scale), frequency, duration of episodes, and functional limitation. Note whether this has been attributed to your HCV by a treating provider.

Worst-day example:

“On my worst days, my knees and wrists are so painful that I cannot grip objects or climb stairs. The joint pain flares alongside my other hepatitis symptoms and has been documented by my rheumatologist as related to my HCV infection.”

What the examiner listens for:

Whether arthralgia is documented as an extrahepatic manifestation of HCV, its severity and functional impact, and whether it is being treated or attributed to the liver disease.

Understatements to avoid:

Do not fail to mention joint pain simply because it does not seem directly related to the liver. HCV arthralgia is a recognized extrahepatic manifestation.

Impact on Work and Daily Activities

How to describe:

Describe how your symptoms have affected your ability to maintain employment, attend appointments, care for yourself, manage a household, and participate in social activities. Use specific examples of tasks you can no longer perform or have had to modify.

Worst-day example:

“I have missed over 30 workdays in the past year due to fatigue, pain, and hepatic episodes. I was placed on reduced duties and ultimately left my job. I rely on family members for grocery shopping, cooking, and housekeeping on my worst days. I have stopped attending social events because of unpredictable symptoms.”

What the examiner listens for:

Functional impairment that goes beyond what lab values alone capture. Examiners must document the functional impact of conditions for rating purposes under M21-1 guidance.

Understatements to avoid:

Do not say 'I manage' or 'I get by' if you have significantly altered your life to accommodate your symptoms. Describe the real, unfiltered impact of your worst days.

Common Mistakes to Avoid

Prep Checklist

0/26 complete

Before Your Exam

Day Of

During the Exam

After the Exam

Your Rights During a C&P Exam

  • You have the right to record your C&P examination in most states. Notify the examiner at the beginning of the exam. Check your state's consent laws beforehand.
  • You have the right to request a copy of the completed DBQ and C&P examination report. Request it through MyHealtheVet, your VSO, or a FOIA request.
  • You have the right to request a new or additional C&P examination if you believe the original was inadequate, rushed, or failed to capture all your symptoms. This can be pursued through a supplemental claim or appeal.
  • You have the right to submit a personal statement (VA Form 21-4138) describing your symptoms and functional limitations in your own words. This can be submitted before, during, or after the exam process.
  • You have the right to submit buddy statements (VA Form 21-10210) from family members, caregivers, or fellow veterans who can corroborate your symptoms and functional limitations.
  • You have the right to have a VSO (Veterans Service Organization), accredited claims agent, or VA-accredited attorney represent you at no charge for claims representation.
  • You have the right to review your VA claims file (C-file). Request a copy through your VSO or directly from VA to ensure all relevant records are included.
  • You have the right to an independent medical examination (IME) from a private physician. A private nexus letter or DBQ completed by your own treating specialist can be submitted as evidence and may rebut an inadequate VA examination.
  • Under the PACT Act and other legislation, certain veterans who served in specific locations or had documented in-service exposures may have presumptive service connection eligibility. Consult your VSO about whether any presumptive provisions apply to your HCV claim.
  • If your rating decision is unfavorable, you have the right to appeal via three lanes: Supplemental Claim (new and relevant evidence), Higher-Level Review (de novo review by senior rater), or Board of Veterans' Appeals (BVA). You have one year from the date of your rating decision to initiate an appeal.
  • You have the right to a rating based on the most favorable interpretation of the evidence. Under the benefit of the doubt standard (38 USC - 5107(b)), when there is an approximate balance of positive and negative evidence, the decision must be made in the veteran's favor.
  • You have the right to a thorough, contemporaneous examination. The examiner must review all evidence of record, conduct an in-person examination (unless a records-only review is explicitly warranted), and provide a fully explained opinion. An inadequate examination can be challenged on appeal.

Related Conditions

Get Personalized C&P Exam Preparation

Upload your medical records for AI-powered prep that maps YOUR symptoms to the exact DBQ fields your examiner will evaluate.

Start Free Analysis Sign in for personalized prep

This C&P exam preparation guide is for educational purposes only and does not constitute legal, medical, or claims advice. Always consult with a qualified Veterans Service Organization (VSO) representative or VA-accredited attorney for guidance specific to your claim. Never exaggerate, minimize, or fabricate symptoms during a C&P examination.